# PIPAC for Peritoneal Metastases of Colorectal Cancer

> **NCT03246321** · PHASE2 · COMPLETED · sponsor: **Koen Rovers** · enrollment: 20 (actual)

## Conditions studied

- Colorectal Neoplasms
- Peritoneal Neoplasms
- Appendiceal Neoplasms
- Peritoneal Carcinomatosis

## Interventions

- **COMBINATION_PRODUCT:** repetitive ePIPAC-OX

## Key facts

- **NCT ID:** NCT03246321
- **Lead sponsor:** Koen Rovers
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2019-10-01
- **Final completion:** 2019-10-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03246321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03246321, "PIPAC for Peritoneal Metastases of Colorectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03246321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*